Does PAMIDRONATE Cause Malignant neoplasm progression? 103 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 103 reports of Malignant neoplasm progression have been filed in association with PAMIDRONATE (Pamidronate Disodium). This represents 6.3% of all adverse event reports for PAMIDRONATE.
103
Reports of Malignant neoplasm progression with PAMIDRONATE
6.3%
of all PAMIDRONATE reports
33
Deaths
17
Hospitalizations
How Dangerous Is Malignant neoplasm progression From PAMIDRONATE?
Of the 103 reports, 33 (32.0%) resulted in death, 17 (16.5%) required hospitalization.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PAMIDRONATE. However, 103 reports have been filed with the FAERS database.
What Other Side Effects Does PAMIDRONATE Cause?
Osteonecrosis of jaw (313)
Drug ineffective (180)
Pain (164)
Off label use (143)
Pyrexia (106)
Dyspnoea (102)
Fatigue (97)
Pain in jaw (97)
Metastases to bone (95)
Back pain (91)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which PAMIDRONATE Alternatives Have Lower Malignant neoplasm progression Risk?
PAMIDRONATE vs PAMIDRONIC ACID
PAMIDRONATE vs PANCRELIPASE
PAMIDRONATE vs PANCRELIPASE AMYLASE\PANCRELIPASE LIPASE\PANCRELIPASE PROTEASE
PAMIDRONATE vs PANCURONIUM
PAMIDRONATE vs PANITUMUMAB